Adding cognitive behavioral therapy (CBT) to pharmacologic treatment for obsessive-compulsive disorder (OCD) in young patients enhanced response, researchers found.
Click here for the full story: http://www.medpagetoday.com/Psychiatry/GeneralPsychiatry/28628
This study showed that in a randomized controlled trial, significantly more patients on the combination were considered responders than those who had drug therapy alone, or drug therapy plus “brief” CBT.
Children with OCD are currently treated with serotonin reuptake inhibitors, the researchers said. Yet the majority have only a partial response, so some argue that augmenting drug therapy with short-term, OCD-specific CBT may add benefits.
Franklin and colleagues found that the combination therapy of medication plus CBT was superior to the other two strategies on all outcome measures.
They estimated the number of weeks needed to treat with the drug and CBT combination therapy versus medication alone to be three, which was the same when comparing the full combination with drug-plus-brief-CBT.
When comparing the drug-plus-brief-CBT with medical management alone, the estimated number needed to treat rose to 25, Franklin and colleagues reported.
Though the study may be limited in generalizability because it didn’t include many minority participants, the researchers still concluded that the findings “highlight the importance of disseminating CBT for pediatric OCD into community settings so that affected children have options beyond medication management alone.”
No comments:
Post a Comment